Madrigal Pharmaceuticals
Get verified emails for Madrigal Pharmaceuticals employees
About Madrigal Pharmaceuticals
|
|
|
51-200 employees
View all
|
|
Pharmaceuticals
|
|
200 Barr-Harbor Dr, Suite 200, Conshohocken, Pennsylvania 19428, US
|
|
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), a liver disease with high unmet medical need. Madrigal’s lead candidate, resmetirom, is a once daily, oral, thyroid hormone receptor (THR)-β selective agonist that is designed to target key underlying causes of NASH in the liver. Resmetirom is currently being evaluated in two Phase 3 clinical studies, MAESTRO-NASH and MAESTRO-NAFLD-1, designed to demonstrate multiple benefits in patients with NASH. For more information, visit www.madrigalpharma.com.
|
Madrigal Pharmaceuticals Email Format
The widely used Madrigal Pharmaceuticals email format is {first}@madrigalpharma.com (e.g. [email protected]), which is used 50% of the time.
| Madrigal Pharmaceuticals Email Formats | Example Email Formats | Percentage |
|---|---|---|
| {first} | [email protected] |
50%
|
Madrigal Pharmaceuticals Alternatives
Frequently Asked Questions about Madrigal Pharmaceuticals
What is Madrigal Pharmaceuticals email format?
The widely used Madrigal Pharmaceuticals email format is {first} (e.g. [email protected]) with 50% adoption across the company.
What is Madrigal Pharmaceuticals customer service number?
To contact Madrigal Pharmaceuticals customer service number in your country click here to find.
Madrigal Pharmaceuticals Staff Directory
Search Madrigal Pharmaceuticals Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Search Portal
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
